Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.
about
Host-Targeting Agents to Prevent and Cure Hepatitis C Virus InfectionPredictive factors for sustained virological response after treatment with pegylated interferon α-2a and ribavirin in patients infected with HCV genotypes 2 and 3The missing pieces of the HCV entry puzzle.Risk factors for fatty liver in the Multicenter AIDS Cohort Study.Autophagy in HCV infection: keeping fat and inflammation at bayInsulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progressionElevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsiesNormocaloric low cholesterol diet modulates Th17/Treg balance in patients with chronic hepatitis C virus infection.Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus.Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients.Syndecan 4 is involved in mediating HCV entry through interaction with lipoviral particle-associated apolipoprotein EProduction and characterization of high-titer serum-free cell culture grown hepatitis C virus particles of genotype 1-6.Hepatitis C Virus Core Protein Promotes miR-122 Destabilization by Inhibiting GLD-2.Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free TreatmentApolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C.Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis ProgramsLipid profile in cirrhotic patients and its relation to clinical outcomeInterferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration.Retrospective study of the associations between hepatitis C virus infection and metabolic factors.How hepatitis C virus invades hepatocytes: the mystery of viral entryUnfolded protein response in hepatitis C virus infection.Functional Analysis of Hepatitis C Virus (HCV) Envelope Protein E1 Using a trans-Complementation System Reveals a Dual Role of a Putative Fusion Peptide of E1 in both HCV Entry and Morphogenesis.Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation.Extracellular lipid-free apolipoprotein E inhibits HCV replication and induces ABCG1-dependent cholesterol efflux.Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus Infection.Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.Interferon Control of the Sterol Metabolic Network: Bidirectional Molecular Circuitry-Mediating Host Protection.Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.Hepatitis C virus and proprotein convertase subtilisin/kexin type 9: a detrimental interaction to increase viral infectivity and disrupt lipid metabolism.Treatment-Induced Viral Cure of Hepatitis C Virus-Infected Patients Involves a Dynamic Interplay among three Important Molecular Players in Lipid Homeostasis: Circulating microRNA (miR)-24, miR-223, and Proprotein Convertase Subtilisin/Kexin Type 9.Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitis.Apolipoprotein E-ε4 deficiency and cognitive function in hepatitis C virus-infected patients.SMAD About Hepatitis C Virus Cell Entry and Liver Disease.New tool for the study of hepatitis C virus genotype 3 and its associated liver disease biology.Rapid Changes in Serum Lipid Profiles during Combination Therapy with Daclatasvir and Asunaprevir in Patients Infected with Hepatitis C Virus Genotype 1b.Hepatitis C virus: Enslavement of host factors.No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV.Study of changes in lipid profile and insulin resistance in Egyptian patients with chronic hepatitis C genotype 4 in the era of DAAs.To determine correlation between biochemical parameters of nutritional status with disease severity in HCV related liver cirrhosis.Role of Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.
P2860
Q26779128-CB8FAED6-CC26-4E0B-9DD7-A78A0016D1C4Q28543090-47D79827-DF72-4FB4-9EBB-19A6E825178EQ33360674-40DD1922-7E05-489C-99DC-C7CB43D366AAQ34049896-D97CEEA1-17C5-4906-8271-89D65A4FFE69Q34069393-10FB8400-08F8-4429-8D4F-378C4C00B407Q34263370-310B3FC1-5670-4D09-A8D3-DEF141B30EA2Q34467266-CD24AAEE-BEEA-4E35-B00C-8BE09065E120Q34756669-8BDFCA79-6D20-4D71-87AB-95B344DF80FBQ35115534-7296F7C4-F49C-43BC-80CE-F1097E262773Q35122536-DDD03764-6717-4381-9506-392C57F6D979Q35153978-1715BDBA-F47B-4A54-8EE9-CDE5CE7132BAQ35557533-E5DF4256-7521-42DB-8A66-839EB709EAD4Q36065720-7BF3B88B-6A2B-46AD-820D-B170D1F1115DQ36146807-657BF906-BBBB-405D-BDB5-C00F0CCA1185Q36233117-FBDD4EDF-FF03-4128-878B-8581BB97459AQ36364602-F45D3E75-B508-47CA-A1C0-72C6CF177187Q36533249-A5115E0E-2A97-4864-BDE6-A8F9545A199FQ36837502-14FDEAEA-BDCC-4B6D-AC8E-653E00C1789DQ37374053-DB18D0C9-349D-4D7A-9F17-59D6BAC2D53BQ37682499-B0D11BFA-DFC8-45E9-9E41-B612ADC73FC6Q38218108-41880507-C955-459E-9E06-0BC3361FD086Q38720669-8C4856E1-5AE6-4EDE-AAE9-1FB80FE0C834Q38743914-10111C17-39FF-4F35-83C0-57214A210391Q38747495-E27650D6-9B67-4F1D-9255-B73A6E5BF5A9Q38765582-23998C9E-4F94-44B4-AFB8-9202B65CE834Q38964215-A0447871-6FE1-4EFE-BD37-7CE60B89F911Q39076009-508321E8-BA10-4E4C-A6A9-23B83A02069BQ39380623-15CFBD39-C885-4A7E-91B2-681D8890CCE5Q39443793-E5761E35-CB9D-470C-BB87-499F45603B5EQ40061048-A1D76538-BFC6-41FC-AB9A-8EFDC743DCF9Q40484068-F14A9FD1-BF9C-4877-999B-F976052B607BQ40607877-52732B2D-5090-4156-B5DB-2C35D869A0E3Q42320803-AB131E57-DC13-43EF-8C51-CC71C08146CEQ43036824-E9BB6884-24E1-4660-9010-BE6FA043CD20Q45323722-F90669D7-CCC2-48C5-89A3-DAE89B4C3F7FQ47251889-3C46D455-D744-4AEE-A4DE-B4B60FED6EFEQ47574522-9470B6F0-6D0D-4C8E-B78E-CC0E5DE6F8BBQ49942281-528B1338-B0BE-4C69-BF78-79D41C12571DQ54967678-87C9A794-9A5C-4364-B2CB-F6F47978F89DQ55473444-86367C8B-E5D1-4AC4-BD3A-AD19C1798ECC
P2860
Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatitis C virus, cholesterol ...... pathogenesis of liver disease.
@en
Hepatitis C virus, cholesterol ...... pathogenesis of liver disease.
@nl
type
label
Hepatitis C virus, cholesterol ...... pathogenesis of liver disease.
@en
Hepatitis C virus, cholesterol ...... pathogenesis of liver disease.
@nl
prefLabel
Hepatitis C virus, cholesterol ...... pathogenesis of liver disease.
@en
Hepatitis C virus, cholesterol ...... pathogenesis of liver disease.
@nl
P2093
P2860
P921
P356
P1433
P1476
Hepatitis C virus, cholesterol ...... pathogenesis of liver disease.
@en
P2093
Catherine Schuster
Daniel J Felmlee
Mathieu Lefevre
Thomas F Baumert
P2860
P304
P356
10.3390/V5051292
P5008
P577
2013-05-23T00:00:00Z